. 2005 Nov;60(5):508–518. doi: 10.1111/j.1365-2125.2005.02483.x

Table 2.

Absorption rate constants for CYP inhibitors involved in in vivo interaction studies

Inhibitor	CYP enzyme	k_a (min⁻¹)	Reference
Sulphaphenazole	2C9	0.030	[9]
Fluconazole	2C9, 3A4	0.061	[33]
Ketoconazole	2C9, 3A4	0.013	[34]
Itraconazole	3A4	0.020	[35]
Quinidine	2D6, 3A4	0.014	[36]
Fluoxetine	2D6, 3A4	0.009	[37]
Fluvoxamine	2C9, 2D6, 3A4	0.008	[38]
Sertraline	2C9, 2D6	0.007	[37]
Citalopram	2D6	0.024	[37]
Nifedipine	3A4	0.056	[39]